A microRNA cocktail weakens brain tumors in preclinical trials

A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has emerged as a promising active agent against tumors of the central nervous system, such as glioblastoma.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup